Your browser doesn't support javascript.
loading
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Krämer, Pauline; Talhouk, Aline; Brett, Mary Anne; Chiu, Derek S; Cairns, Evan S; Scheunhage, Daniëlla A; Hammond, Rory F L; Farnell, David; Nazeran, Tayyebeh M; Grube, Marcel; Xia, Zhouchunyang; Senz, Janine; Leung, Samuel; Feil, Lukas; Pasternak, Jana; Dixon, Katherine; Hartkopf, Andreas; Krämer, Bernhard; Brucker, Sara; Heitz, Florian; du Bois, Andreas; Harter, Philipp; Kommoss, Felix K F; Sinn, Hans-Peter; Heublein, Sabine; Kommoss, Friedrich; Vollert, Hans-Walter; Manchanda, Ranjit; de Kroon, Cornelis D; Nijman, Hans W; de Bruyn, Marco; Thompson, Emily F; Bashashati, Ali; McAlpine, Jessica N; Singh, Naveena; Tinker, Anna V; Staebler, Annette; Bosse, Tjalling; Kommoss, Stefan; Köbel, Martin; Anglesio, Michael S.
Afiliação
  • Krämer P; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Talhouk A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Brett MA; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Chiu DS; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • Cairns ES; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Scheunhage DA; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • Hammond RFL; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Farnell D; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Nazeran TM; Department of Pathology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.
  • Grube M; Barts Health National Health Service Trust, Department of Pathology, London, United Kingdom.
  • Xia Z; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • Senz J; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Leung S; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • Feil L; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Pasternak J; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Dixon K; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • Hartkopf A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Krämer B; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • Brucker S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Heitz F; BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, British Columbia, Canada.
  • du Bois A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Harter P; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Kommoss FKF; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Sinn HP; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Heublein S; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Kommoss F; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Vollert HW; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Manchanda R; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • de Kroon CD; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
  • Nijman HW; Charité Campus Virchow-Klinikum, Department for Gynecology with the Center for Oncologic Surgery, Berlin, Germany.
  • de Bruyn M; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
  • Thompson EF; Kliniken Essen Mitte, Department of Gynecology and Gynecologic Oncology, Essen, Germany.
  • Bashashati A; Heidelberg University Hospital, Institute of Pathology, Heidelberg, Germany.
  • McAlpine JN; Heidelberg University Hospital, Institute of Pathology, Heidelberg, Germany.
  • Singh N; Department of Obstetrics and Gynecology, Heidelberg University Hospital, Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany.
  • Tinker AV; Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany.
  • Staebler A; Department of Obstetrics and Gynecology, Medizin Campus Bodensee, Friedrichshafen, Germany.
  • Bosse T; Barts CRUK Cancer Centre, Wolfson Institute of Preventative Medicine, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Kommoss S; Department of Gynaecological Oncology, St. Bartholomew's Hospital, London, United Kingdom.
  • Köbel M; Department of Gynecology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.
  • Anglesio MS; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Clin Cancer Res ; 26(20): 5400-5410, 2020 10 15.
Article em En | MEDLINE | ID: mdl-32737030
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Proteína Supressora de Tumor p53 / Carcinoma Endometrioide / Carcinoma Epitelial do Ovário Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Proteína Supressora de Tumor p53 / Carcinoma Endometrioide / Carcinoma Epitelial do Ovário Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article